Literature DB >> 33089879

Absolute Resting 13N-Ammonia PET Myocardial Blood Flow for Predicting Myocardial Viability and Recovery of Ventricular Function after Coronary Artery Bypass Grafting.

Jiao Wang1, Jian-Ming Li2, Shuai Li1, Bailing Hsu3.   

Abstract

OBJECTIVE: We aimed to evaluate the feasibility of resting myocardial blood flow (rMBF), quantified with dynamic 13 N-Ammonia (NH3) PET, for identifying myocardial viability and predicting improvement of left ventricular ejection fraction (LVEF) after coronary artery bypass grafting (CABG).
METHODS: Ninety-three patients with coronary artery disease (CAD) and chronic LVEF < 45%, scheduled for CABG, had dynamic 13NH3 PET and 18F-FDG PET imaging. The perfusion/metabolism polar maps were categorized in four patterns: normal (N), mismatch (M1), match (M2) and reverse mismatch (RM). The value of rMBF for identifying viable myocardium (M1, RM) and post CABG improvement of LVEF≥8% was analyzed by receiver operating characteristic (ROC) curves. Correlations of rMBF in segments to ΔLVEF post CABG were verified.
RESULTS: Mean rMBFs were significantly different (N=0.60±0.14; M1=0.44±0.07, M2=0.34±0.08, RM=0.53±0.09 ml/min/g, P<0.001). The optimal rMBF cutoff to identify viable myocardium was 0.42 ml/min/g (sensitivity=88.3%, specificity=82.0%) and 0.43 ml/min/g for predicting improvement of LVEF ≥8% (74.6%, 80.0%). The extent and rMBF of combined M1/RM demonstrated a moderate to high correlation to improved LVEF (r=0.78, 0.71, P<0.001).
CONCLUSION: Resting MBF, derived by dynamic 13NH3 PET, may be positioned as a supplement to 18F-FDG PET imaging for assessing the presence of viable myocardium and predicting potential improvement of LVEF after CABG.
© 2020. American Society of Nuclear Cardiology.

Entities:  

Keywords:  13N-Ammonia; 18F-FDG; Coronary artery bypass grafting; Coronary artery disease; Myocardial blood flow; Myocardial viability; Positron emission computed tomography

Mesh:

Substances:

Year:  2020        PMID: 33089879     DOI: 10.1007/s12350-020-02388-7

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   3.872


  3 in total

1.  Impact of diabetes mellitus on prediction of clinical outcome after coronary revascularization by 18F-FDG SPECT in patients with ischemic left ventricular dysfunction.

Authors:  Arend F L Schinkel; Don Poldermans; Vittoria Rizzello; Ron T van Domburg; Roelf Valkema; Abdou Elhendy; Elena Biagini; Eric P Krenning; Maarten L Simoons; Jeroen J Bax
Journal:  J Nucl Med       Date:  2006-01       Impact factor: 10.057

2.  PET should replace SPECT in cardiac imaging for diagnosis and risk assessment of patients with known or suspected CAD: Pro.

Authors:  Jamshid Maddahi; René R Sevag Packard
Journal:  J Nucl Cardiol       Date:  2017-04-10       Impact factor: 5.952

3.  Value of 12-lead electrocardiogram to predict myocardial scar on FDG PET in heart failure patients.

Authors:  Susanne Markendorf; Dominik C Benz; Michael Messerli; Marvin Grossmann; Andreas A Giannopoulos; Dimitri Patriki; Tobias A Fuchs; Christoph Gräni; Aju P Pazhenkottil; Ronny R Buechel; Philipp A Kaufmann; Oliver Gaemperli
Journal:  J Nucl Cardiol       Date:  2019-08-09       Impact factor: 5.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.